Exelixis Inc Net Income per Employee (EXEL), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Exelixis Inc   (NASDAQ: EXEL)
 

Exelixis Inc Net Income per Employee

EXEL's Quarterly Results, Trends, Rankings, Statistics
With an income increase of 14.32% in the second quarter 2026, year on year to cumulative value of $1,896 million, and with 1,147 employees, Exelixis Inc 's income per employee grew on trailing twelve month basis to $ 1,653,085, this marks a new company high for all of 1,147 employees.
The Healthcare sector has seen employees of 2 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 128, from total ranking in previous quarter at 129.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

EXEL Net Income per Employee (Jul 03 2026)
II. Quarter		 (Apr 03 2026)
I. Quarter		 (Jan 02 2026)
IV. Quarter		 (Oct 03 2025)
III. Quarter		 (Jul 04 2025)
II. Quarter
Y / Y Net Income Change 14.32 % 30.89 % 53.16 % 63.53 % -19.98 %
Net Income per Employee (TTM) $ 1,653,085 1,601,242 1,502,856 1,352,392 1,201,335
EXEL's Total Ranking # 128 # 129 # 28 # 71 # 68
Seq. Net Income Change -0.72 % -3.83 % 11.49 % 7.4 % 13.68 %

EXEL Company Profile >> Back to EXEL Efficiency Comparisons >> Compare EXEL Net Income per Employee to its Competitors

EXEL Net Income per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 3
Healthcare Sector # 18
Overall Market # 128

Net Income per Employee Statistics
High Average Low
$ 1,653,085 $ 297,105 $ -249,258
(Jul 03 2026)   (Jun 30 2014)







Companies with similar Income per Employee for 12 month ending Jul 03 2026, within Healthcare Sector Income per Employee Income 12 month ending Jul 03 2026Number of Employees Jul 03 2026
Aurinia Pharmaceuticals Inc   2,454,015.63 $ 314.114  Million 128 
Innoviva Inc   2,246,767.30 $ 357.236  Million 159 
Quince Therapeutics Inc   2,060,342.11 $ 78.293  Million 38 
Fortress Biotech Inc   2,030,307.69 $ 158.364  Million 78 
Elutia Inc   1,992,615.38 $ 51.808  Million 26 
Rigel Pharmaceuticals Inc  1,850,051.72 $ 321.909  Million 174 
Exelixis Inc   1,653,085.44 $ 1,896.089  Million 1,147 
Actinium Pharmaceuticals Inc  1,514,120.00 $ 37.853  Million 25 
Q32 Bio Inc   1,407,750.00 $ 33.786  Million 24 
Ironwood Pharmaceuticals inc   1,298,680.00 $ 129.868  Million 100 
Agenus Inc  1,135,037.04 $ 91.938  Million 81 
Tg Therapeutics Inc   1,106,491.23 $ 441.490  Million 399 
Halozyme Therapeutics Inc   977,768.32 $ 413.596  Million 423 
Zevra Therapeutics Inc   949,245.90 $ 57.904  Million 61 
United Therapeutics Corporation  936,357.14 $ 1,310.900  Million 1,400 
Protagenic Therapeutics Inc new  910,314.00 $ 5.462  Million 6 
Elite Pharmaceuticals Inc   871,814.86 $ 56.668  Million 65 


Date modified: 2026-09-13T23:29:29+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.